The Adverse Impact of Cyclosporine on Serum Lipids in Renal Transplant Recipients
- 1 June 1991
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 17 (6) , 700-707
- https://doi.org/10.1016/s0272-6386(12)80355-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- LIPID ABNORMALITIES IN CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTSTransplantation, 1989
- High density lipoprotein cholesterol is reduced in patients with sarcoidosisThe American Journal of Medicine, 1989
- THE RELATIONSHIP BETWEEN CYCLOSPORINE PHARMACOKINETIC PARAMETERS AND SUBSEQUENT ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1988
- Central Nervous System Toxicity after Liver TransplantationNew England Journal of Medicine, 1987
- Interaction of cyclosporin A with human lipoproteinsJournal of Pharmacy and Pharmacology, 1986
- Increased Low-Density Lipoprotein Levels After Splenectomy: A Role for the Spleen in Cholesterol Metabolism in Myeloproliferative DisordersThe Lancet Healthy Longevity, 1986
- Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.Journal of Clinical Investigation, 1984
- Effect of alternate-day prednisone on plasma lipids in renal transplant recipientsKidney International, 1982
- Plasma lipids in kidney transplanted children and adolescents: influence of pubertal development, dietary intake and steroid therapyEuropean Journal of Clinical Investigation, 1981
- Lipid Disorders in Renal Transplant RecipientsNephron, 1978